pp电子网址
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.07.09
金融衍生品交易业务内部控制制度(2016年7月)
2016.07.09
关于公司与花旗银行进行交叉货币掉期交易的公告
2016.07.09
第三届董事会第二十四次会议决议公告
2016.07.05
关于公司员工持股计划完成出售的公告
2016.06.28
第三届董事会第二十三次会议决议公告
2016.06.28
关于召开2016年第一次临时股东大会的通知公告
2016.06.28
关于审计部经理退休的公告
2016.06.23
关于完成工商登记变更的公告
2016.06.21
关于公司使用自有资金购买低风险理财产品的进展公告
2016.06.17
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS V,L.P.投资的公告
第一页
上一页
88
89
90
91
92
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.